HomeComparePLTZ vs JNJ

PLTZ vs JNJ: Dividend Comparison 2026

PLTZ yields 6.81% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLTZ wins by $11.4K in total portfolio value
10 years
PLTZ
PLTZ
● Live price
6.81%
Share price
$29.35
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.4K
Annual income
$1,050.75
Full PLTZ calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — PLTZ vs JNJ

📍 PLTZ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPLTZJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PLTZ + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PLTZ pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PLTZ
Annual income on $10K today (after 15% tax)
$579.22/yr
After 10yr DRIP, annual income (after tax)
$893.14/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, PLTZ beats the other by $189.52/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PLTZ + JNJ for your $10,000?

PLTZ: 50%JNJ: 50%
100% JNJ50/50100% PLTZ
Portfolio after 10yr
$25.7K
Annual income
$939.26/yr
Blended yield
3.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PLTZ
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PLTZ buys
0
JNJ buys
0
No recent congressional trades found for PLTZ or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPLTZJNJ
Forward yield6.81%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$31.4K$20.0K
Annual income after 10y$1,050.75$827.78
Total dividends collected$8.7K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PLTZ vs JNJ ($10,000, DRIP)

YearPLTZ PortfolioPLTZ Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,381$681.43$10,676$355.77+$705.00PLTZ
2$12,903$724.83$11,407$389.39+$1.5KPLTZ
3$14,574$767.97$12,198$426.53+$2.4KPLTZ
4$16,405$810.69$13,056$467.62+$3.3KPLTZ
5$18,406$852.83$13,987$513.12+$4.4KPLTZ
6$20,589$894.27$14,998$563.56+$5.6KPLTZ
7$22,965$934.87$16,098$619.52+$6.9KPLTZ
8$25,547$974.54$17,295$681.69+$8.3KPLTZ
9$28,349$1,013.19$18,599$750.82+$9.8KPLTZ
10$31,384$1,050.75$20,022$827.78+$11.4KPLTZ

PLTZ vs JNJ: Complete Analysis 2026

PLTZStock

The Defiance Daily Target 2X Short PLTR ETF (the “Fund”) seeks daily investment results, before fees and expenses, of two times the inverse (-200%) of the daily percentage change in the share price of Palantir Technologies Inc. (NYSE: PLTR). Because the Fund seeks daily inverse leveraged investment results, it is very different from most other exchange-traded funds and there is no guarantee that the Fund will meet its stated objective. The Fund should not be expected to provide -200% of the cumulative return of PLTR for periods greater than a single trading day.

Full PLTZ Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this PLTZ vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PLTZ vs SCHDPLTZ vs JEPIPLTZ vs OPLTZ vs KOPLTZ vs MAINPLTZ vs ABBVPLTZ vs MRKPLTZ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.